Med. praxi. 2018;15(3):145-149 | DOI: 10.36290/med.2018.029

Painful lesions of cranial nerves lesions and other orofacial pain syndromes

MUDr. Andrea Bártková, Ph.D.
Neurologická klinika LF UP a FN Olomouc

Orofacial pain is a widespread clinical syndrome associated with high morbidity and significant interference with the quality oflife of the affected persons. Orofacial pain can arise from different regions and etiologies. Many orofacial pain conditions haveoverlapping presentations, and diagnostic uncertainty is frequently encountered in clinical practice. Multidisciplinary approachand solid knowledge of the complex anatomy and physiology of the orofacial region is necessary. This statement focuses primarilyon painful cranial nerve lesions and some rare facial pain syndromes based on a new version International classificationof headache disorders.

Keywords: orofacial pain, trigeminal neuralgia, trigeminal neuropathy, rare orofacial pain syndrome

Published: July 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bártková A. Painful lesions of cranial nerves lesions and other orofacial pain syndromes. Med. praxi. 2018;15(3):145-149. doi: 10.36290/med.2018.029.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Benoliel R, Birman N, Eliav E, et al. The International Classification of Headache Disorders: Accurate diagnosis of orofacial pain? Cephalalgia. 2008; 28: 752-762. Go to original source... Go to PubMed...
    2. The International Classification of Headache Disorders. 3rd edition. Cephalalgia 2018; 38(1): 1-211. Go to original source...
    3. Katusic S, Williams DB, Beard CM, et al. Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984. Neuroepidemiology 1991; 10: 276. Go to original source... Go to PubMed...
    4. MacDonald BK, Cockerell OC, Sander JW, et al. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000; 123(Pt 4): 665. Go to original source... Go to PubMed...
    5. Gronseth G, Cruccu G, Alksne J, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of ocieties. Neurology 2008; 71: 1183. Go to original source... Go to PubMed...
    6. Bennetto L, Patel NK, Fuller G. Trigeminal neuralgia and its management. BMJ 2007; 334: 201. Go to original source... Go to PubMed...
    7. Watson CP, Evans RJ, Watt VR. Post-herpetic neuralgia and topical capsaicin. Pain 1988; 33: 333. Go to original source... Go to PubMed...
    8. Edelsberg JS, Lord C, Oster G. Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia. Ann Pharmacother 2011; 45: 1483. Go to original source... Go to PubMed...
    9. Zhang H, Lian Y, Ma Y, et al. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial. Headache Pain 2014; 15(1): 65. Go to original source... Go to PubMed...
    10. Bescós A, Pascual V, Escosa-Bage M, et al. Treatment of trigeminal neuralgia: an update and future prospects of percutaneous techniques. Rev Neurol. 2015; 61(3): 114-24. Go to original source...
    11. Bick SKB, Eskandar EN. Surgical Treatment of Trigeminal Neuralgia. Neurosurg Clin N Am. 2017; 28(3): 429-438. Go to original source... Go to PubMed...
    12. Masopust V. Léčba neuralgie trigeminu. Sanquis 2005; 41: 40.
    13. Weber K. Neuromodulation and Devices in Trigeminal Neuralgia. Headache 2017; 57(10): 1648-1653. Go to original source... Go to PubMed...
    14. Urgošík D, Liščák R. Léčba gama nožem u algických syndromů v inervační oblasti nervus glossopharyngeus. Cesk Slov Neurol N 2016; 79/112(3): 331-335. Go to original source...
    15. Galli F, Lodi G, Sardella A, et al. Role of psychological factors in burning mouth syndrome: A systematic review and meta-analysis. Cephalalgia 2017; 37: 265. Go to original source... Go to PubMed...
    16. Dieleman JP, Kerklaan J, Huygen FJ, et al. Incidence rates and treatment of neuropathic pain conditions in the general population. Pain 2008; 137: 681. Go to original source... Go to PubMed...
    17. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17: 1113. Go to original source... Go to PubMed...
    18. Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain-United States, 2016. JAMA 2016; 315: 1624. Go to original source... Go to PubMed...
    19. Marková J. Léze trigeminu. Neurol praxi 2012; 13(5): 253-258.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.